GRIN2B基因编码N-甲基-D-天冬氨酸(NMDA)受体的一种亚基,即GluN2B,属于离子型谷氨酸受体家族。NMDA受体是中枢神经系统中重要的兴奋性神经递质受体,参与突触可塑性、学习记忆等关键神经功能。GRIN2B基因主要在发育早期的大脑皮层和海马区高表达,随着年龄增长表达量逐渐降低。GluN2B亚基决定了NMDA受体的多种特性,包括对镁离子的敏感性、通道开放时间和钙离子通透性等。GRIN2B基因突变与多种神经系统疾病相关,如智力障碍、癫痫、自闭症谱系障碍和精神分裂症。功能丧失性突变通常导致严重的神经发育障碍,而某些错义突变可能改变受体功能,引起过度兴奋或抑制。GRIN2B基因过表达可能增加突触的NMDA受体数量,增强突触可塑性,但也可能导致钙离子超载引发兴奋性毒性;表达降低则可能损害突触功能,影响认知能力。该基因属于GRIN基因家族,该家族成员均编码NMDA受体的不同亚基,共同特点是形成异四聚体离子通道,需要甘氨酸和谷氨酸共同激活,并在突触可塑性和神经发育中起核心作用。GRIN2B与GRIN2A等其他亚基存在功能互补和竞争关系,不同发育阶段和脑区的亚基组合变化对神经功能产生重要影响。
N-methyl-D-aspartate (NMDA) receptors are a class of ionotropic glutamate receptors. NMDA receptor channel has been shown to be involved in long-term potentiation, an activity-dependent increase in the efficiency of synaptic transmission thought to underlie certain kinds of memory and learning. NMDA receptor channels are heteromers composed of three different subunits: NR1 (GRIN1), NR2 (GRIN2A, GRIN2B, GRIN2C, or GRIN2D) and NR3 (GRIN3A or GRIN3B). The NR2 subunit acts as the agonist binding site for glutamate. This receptor is the predominant excitatory neurotransmitter receptor in the mammalian brain. [provided by RefSeq, Jul 2008]
N-甲基-D-天冬氨酸(NMDA)受体是一类离子型谷氨酸受体的。 NMDA受体通道已经显示参与了长时程增强,中认为是背后某些类型的记忆和学习的突触传递的效率的活性依赖性增加。 NMDA受体通道是三个不同的亚基组成的异聚:NR1(GRIN1),NR(GRIN2A,GRIN2B,GRIN2C,或GRIN2D)和NR3(GRIN3A或GRIN3B)。的NR2亚基充当谷氨酸激动剂结合位点。该受体是哺乳动物大脑的主要兴奋性神经递质的受体。 [由RefSeq的,2008年7月提供]
GRIN2B基因(以及对应的蛋白质)的细胞分布位置:
GRIN2B基因的本体(GO)信息:
| 名称 |
|---|
| 4014 Ras signaling pathway [PATH:hsa04014] |
| 4015 Rap1 signaling pathway [PATH:hsa04015] |
| 4024 cAMP signaling pathway [PATH:hsa04024] |
| 4080 Neuroactive ligand-receptor interaction [PATH:hsa04080] |
| 4724 Glutamatergic synapse [PATH:hsa04724] |
| 4728 Dopaminergic synapse [PATH:hsa04728] |
| 4720 Long-term potentiation [PATH:hsa04720] |
| 4713 Circadian entrainment [PATH:hsa04713] |
| 5322 Systemic lupus erythematosus [PATH:hsa05322] |
| 5010 Alzheimer's disease [PATH:hsa05010] |
| 5014 Amyotrophic lateral sclerosis (ALS) [PATH:hsa05014] |
| 5016 Huntington's disease [PATH:hsa05016] |
| 5030 Cocaine addiction [PATH:hsa05030] |
| 5031 Amphetamine addiction [PATH:hsa05031] |
| 5033 Nicotine addiction [PATH:hsa05033] |
| 5034 Alcoholism [PATH:hsa05034] |
| 名称 |
|---|
| Activation of NMDA receptor upon glutamate binding and postsynaptic events |
| Axon guidance |
| CREB phosphorylation through the activation of CaMKII |
| CREB phosphorylation through the activation of Ras |
| Developmental Biology |
| EPH-Ephrin signaling |
| EPHB-mediated forward signaling |
| Neuronal System |
| Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell |
| Post NMDA receptor activation events |
| Ras activation uopn Ca2+ infux through NMDA receptor |
| Transmission across Chemical Synapses |
| Unblocking of NMDA receptor, glutamate binding and activation |
| 疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
| MENTAL RETARDATION, AUTOSOMAL DOMINANT 6 | 0.24 | 2 | 7 | CLINVAR_UNIPROT |
| Epilepsy | 0.200542884 | 4 | 0 | BeFree_CTD_human_RGD |
| Schizophrenia | 0.162449467 | 23 | 4 | BeFree_CTD_human_GAD_LHGDN |
| Intellectual Disability | 0.121085767 | 5 | 0 | BeFree_CTD_human |
| West Syndrome | 0.120271442 | 1 | 0 | BeFree_ORPHANET |
| Child Development Disorders, Pervasive | 0.12 | 1 | 0 | CTD_human |
| Hypotension | 0.12 | 1 | 0 | CTD_human |
| Hyperalgesia | 0.12 | 1 | 0 | CTD_human |
| EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27 | 0.12 | 1 | 0 | UNIPROT |
| Trauma, Nervous System | 0.08 | 1 | 0 | RGD |
山东省济南市章丘区文博路2号 齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号大学科技园北区F座4单元2楼
电话: 0531-88819269
E-mail: product@genelibs.com
关注微信订阅号,实时查看信息,关注医学生物学动态。